Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
From 11th Sept 2020 RNS
The Options granted pursuant to the New Scheme each have an exercise price of £0.01 and will
vest based on the Company's share price during the course of the next three years, between £2.00
and £3.50 ("Target Share Price") (as set out below)
Hi Mark, thanks for taking the time to explain.
I think where i am struggling here is the exercise price. The exercise price on the incentive plan is 0.01p. To me that is the price to purchase
Eg the latest RNS re share options for Cameron has exercise price of 168p .. that i understand,
Hi Buffettt, the SP was over 200p for 20 days earlier in the year so the 1st exercise price has been met, that's my point.
Itsyou has explained it though. It looks like it can only be exercised "being the later of (a) the third anniversary of the date of grant and (b) the date falling 20 business days after the announcement of the Company's results for the financial year ended 31 May 2023"
So the named directors have got some shares coming at least in 2023. !
Yes, good timing for the RNS lol
I think what I am getting at is I am interested why Adam buys shares at market value when he has substantial options that he has not taken. I don't know if it is my understanding of the options that is wrong ? Surely as well if the director has confidence in the SP performance they would not really have any interest to buy shares now when there are options ready at only 20% rise. I am wondering if the recent purchase is just for show ? Just my inquisitive mind really but I have not really had an answer as to whether my understanding is right or wrong. Usually there is someone straight away ready to correct miss-informants lol.
Sorry for going on, I wont mention it again unless anyone does give any education on it.........
Thanks Buffettt
Genuinely, can you educate me then please, from what I read on the incentive plan there is an option to purchase shares, 741,187 at 0.01p if the share price hits 200p for 20 consecutive days which it did this year. There are further options for higher SP's up to 350p. The shares have to be held for 2 years before selling but do not have to be sold.
I would like to see how I am misunderstanding this incentive scheme as obviously it is beneficial for the directors to reach the targets.
Thanks :-)
Thanks Trek
I am not that knowledgeable on the subject. Is my understanding correct that Adam is entitled to have taken 700,000 free shares (because of the SP performance) that he didn’t exercise. I appreciate he has to keep them for 2years but that is over £1m. I can’t get my head round what reason there would be for not taking them ? Maybe I’m way off point..
This may be one for Trek but i was wondering why Adam would buy shares at market rate but didnt take the options for "free shares" when the SP was above 200p for more than 20 days earlier in the year ?
Or am I not understanding the share options correctly ?
I’m no expert on big pharma and only really just dipping my toe in bios but it does seem like really good business sense for a massive pharmaceutical company to own ONC themselves. They need the companies service to research and develop their products along with their competitors. Surely taking it away from the opposition will be a massive business advantage. It not a regulatory company so can be owned by the pharma themselves. Any thoughts ?
http://www.**********.co.uk/articles/oncimmune-discuss-their-highly-profitable-immunoinsights-business-b95d977